| |
| |
|
| Insider
Information: |
Krishnamohan Neha |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
5,607 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$44,800 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,607 |
|
|
| Total
Value |
$44,800 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kinnate Biopharma Inc. |
KNTE |
|
2024-04-03 |
0 |
2022-09-01 |
0 |
Premium* |
|
|
Arcutis Biotherapeutics, Inc. |
ARQT |
Director |
2023-05-31 |
5,607 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNTE |
Kinnate Biopharma Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(64,087) |
0 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-01 |
4 |
D |
$2.59 |
$3,901 |
D/D |
(1,506) |
64,087 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2023-12-01 |
4 |
D |
$2.25 |
$3,283 |
D/D |
(1,459) |
65,593 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2023-09-01 |
4 |
D |
$2.35 |
$3,429 |
D/D |
(1,459) |
67,052 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2023-06-01 |
4 |
D |
$4.30 |
$6,274 |
D/D |
(1,459) |
68,511 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,375 |
5,607 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
D |
$5.21 |
$8,966 |
D/D |
(1,721) |
67,378 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
D |
$7.75 |
$11,307 |
D/D |
(1,459) |
69,099 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Director |
– • – |
2022-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,232 |
|
% |
|
| KNTE |
Kinnate Biopharma Inc. |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
67,500 |
69,015 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
